Autres langues Valiant Laboratories Limited

Actions

VALIANTLAB

INE0JWS01017

Chimie de spécialité

Cours en clôture NSE India S.E. 01/10/2026			Varia. 5j.	Varia. 1 janv.
125,08 ^INR	-0,91%		+0,17%	+78,69%

10/08	Valiant Laboratories Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI
10/08	Valiant Laboratories Limited approuve l'ouverture d'un nouveau siège social	CI

Autres langues

29/09	Valiant Laboratories Limited Announces Change in Registered Office Address
10/08	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
10/08	Valiant Laboratories Limited Approves the Opening of New Corporate Office
20/05	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.
14/05	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
23/04	Valiant Laboratories Limited Announces Resignation of Bhanudas D. Patil as Q.C Manager, Senior Management Personnel, Effective April 22, 2026
11/02	Valiant Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
15/01	Valiant Laboratories Ltd receives notice for total tax demand of approx. 125.3 million rupees
11/11	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
07/11	Valiant Laboratories Arm Begins Commercial Operations at New Unit in Gujarat, India; Shares Up 4%
25/09/25	Valiant Laboratories Limited Approves Change in Designation of Paresh Shah from Executive Director to Whole-Time Director, Effective September 25, 2025
08/08/25	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
16/07/25	Valiant Laboratories Gets Board Nod for INR815 Million Rights Issue; Shares Up 4%
15/07/25	Valiant Laboratories says rights issue price set at 75 rupees per share, entitlement ratio 1:4
09/07/25	Valiant Laboratories approves rights issue up to 814.7 mln rupees
09/07/25	Valiant Laboratories Gets Board Nod to Raise Up To INR815 Million Through Rights Issue
09/07/25	Valiant Laboratories Limited Approves the Appointment of Akshay Gangurde as Company Secretary and Compliance Officer, Effective July 09, 2025
26/06/25	India Ratings and Research Assigns BBB Long-Term Rating to Valiant Laboratories
20/05/25	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
20/05/25	Valiant Laboratories Limited Announces Executive and Committee Changes, with Effect from May 20, 2025
19/02/25	Crisil Downgrades Valiant Laboratories' Long-Term Bank Financing Rating
20/12/24	Valiant Laboratories Limited Approves Appointment of Ashok Lakhamshi Chheda as Non-Executive Independent Director
12/11/24	Valiant Laboratories Limited Announces Resignation of Velji Karamshi Gogri as the Non- Executive Independent Director
12/11/24	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
06/10/24	18,174,035 Equtiy Shares of Valiant Laboratories Limited are subject to a Lock-Up Agreement Ending on 6-OCT-2024.